You are here
STEMINA BIOMARKER DISCOVERY, INC
UEI: H68RXEVTQCG5
# of Employees: 12
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Amount: $1,254,279.00DESCRIPTION provided by applicant Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Pluripotent Stem Cell Derived Cardiomyocytes Project Summary Abstract Cardiac safety is ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
A Metabolism Based Test to Diagnose Autism Spectrum Disorder and its Subtypes in Early Childhood
Amount: $2,647,138.00DESCRIPTION provided by applicant Autism spectrum disorder ASD is now diagnosed in of children with recent reports citing as many as in children in the United States The average age o ...
SBIRPhase II2015Department of Health and Human Services National Institutes of Health -
Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Plurip
Amount: $146,666.00DESCRIPTION (provided by applicant): Cardiotoxicity, as a result of adverse drug effects, is a serious problem that has yet to be effectively screened prior to patient exposure. Cardiac safety is one ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
SBIR Phase II: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model
Amount: $500,000.00This Small Business Innovation Research (SBIR) Phase II project will fund a continuation of breakthrough research, development and commercialization of an in vitro assay to help prevent birth defects. ...
SBIRPhase II2011National Science Foundation -
Not Available
Amount: $999,936.00Brain tumor stem cells (BTSCs) are a subset population within tumors that are widely believed to be responsible for tumor recurrence, due to their ability to self-renew, differentiate, migrate, and i ...
SBIRPhase II2010Department of Health and Human Services National Institutes of Health -
SBIR Phase I: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model
Amount: $149,255.00This Small Business Innovation Research (SBIR) Phase I project proposes to develop a highly predictive model for assessing the potential of compounds to cause birth defects in the developing human emb ...
SBIRPhase I2009National Science Foundation -
SBIR TOPIC 245 "PREDICTIVE EFFICACY SCREENING IN CANCER STEM CELLS USING METABOLO
Amount: $149,528.00Cancer stem cells (CSCs) are a critical tumor subpopulation that may cause local recurrences that plague patients with advanced solid malignancies, even after maximal therapeutic efforts. CSCs can sel ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health